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INTRODUCTION:  Synovial  sarcomas  commonly  occur  in the  extremities  of  young  adults.  A  primary  occur-
rence  in the  mediastinum  is  very  rare with  only  a few  reported  cases  in  the  world  literature.
We  report  a case  of  mediastinal  synovial  sarcoma.  This  paper  is  about  a 47-year-old  male  who  presented
with  retrosternal  chest  pain  and  shortness  of breath  on  exertion.  Imaging  showed  an  anterior  mediastinal
mass.  Pathological  examination  of the resected  mass  showed  a biphasic  neoplasm  with a spindle  cell
component  admixed  with  gland-like  elements.  The  tumor  showed  positive  staining  with  cytokeratin,
epithelial  membrane  antigen  and  vimentin  conﬁrming  the  diagnosis  of a biphasic  synovial  sarcoma.ediastinal mass
mmunohistochemistry
DISCUSSION:  A  wide  range  of  neoplasms,  both  primary  and  metastatic,  occur  in the  mediastinum,  which
pose considerable  diagnostic  difﬁculties.  A synovial  sarcoma  should  always  be  considered  in  the  differ-
ential  diagnosis,  and  immunohistochemistry  is an  important  adjuvant  tool  in this  situation.
CONCLUSION:  This  paper  highlights  the  importance  of  recognizing  an  unusual  presentation  of  this  aggres-
sive neoplasm  to aid  appropriate  clinical  management.
©  2016  The  Author(s).  Published  by  Elsevier  Ltd  on behalf  of IJS  Publishing  Group  Ltd.  This  is  an  open
he  CCaccess  article  under  t
. Introduction
Synovial sarcoma is a mesenchymal tissue cell tumor that
xhibits epithelial differentiation. Most frequently, it arises in the
xtremities of adolescents and young adults [1], while a primary
ccurrence in the mediastinum is quite rare with only a few
eported cases in the world literature [2]. Primary mediastinal syn-
vial sarcoma is a malignant tumor, can invade adjacent organs
r give distant metastases. Pathological examination are crucial to
stablish diagnosis, as the clinical presentation and imaging pat-
erns are often nonspeciﬁc and misleading. Herein, we report a
ase of 14 cm primary mediastinal synovial sarcoma, diagnosed in
 47-year old male.
. Case report
A 47-year-old man  presented with symptoms of retrosternal
hest pain, not related to physical activity or exertion. He also com-
lained of shortness of breath on exertion. There was  no history
f cough, hemoptysis,fever, or weight loss. Physical examination
id not reveal anything signiﬁcant. His blood investigations at pre-
entation revealed hemoglobin level of 12.5 gm/dL, total leukocyte
ounts of 8500 cells/mm3, and platelet counts of 3,60,000/mm3.
is serum electrolytes, renal function tests, and liver function
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tests were within normal range. Germ cell tumor markers like
lactate-dehydrogenase (LDH), alpha-fetoprotein (AFP), and -
human chorionic gonadotropin (-HCG) levels were within normal
limits. The chest X-ray showed a large mass in left thoracic cav-
ity,adjacent to the mediastinum (Fig. 1A). Computed tomography
(CT) scan revealed a 14 cm heterogeneously anterior mediasti-
nal mass(Fig. 1B). CT guided biopsy was  done. It was  reported
as sarcoma. PET scan was  performed to exclude any metastatic
disease (no other foci that may  represent metastatic disease).
The patient underwent median sternotomy and excision of tumor
was performed. The tumor measured about 14 by 14 by 9.5 cm
(Fig. 2A). Histologically the tumor was composed of spindle cells
and glandular epithelial structures (Fig. 2B). Numerous mitotic ﬁg-
ures (more than 4 per 10 high power ﬁeld) were seen and there
were focal areas of necrosis. Immunohistochemistry demonstrated
strong positivity for Cytokeratins,Vimentin and focal positivity for
epithelial membrane antigen(EMA).Mesothelial markers and pri-
mary pulmonary tumor marker(TTF-1) were negative. With the
combination of histopathological features and immunohistochem-
ical ﬁndings a diagnosis of a primary biphasic synovial sarcoma of
the mediastinum was offered. Postoperative recovery was smooth.
The patient received adjuvant chemotherapy.patient is on regular
follow up without evidence of residual or recurrent disease.
3. DiscussionThe term synovial sarcoma is a misnomer because the tumor
does not arise from the synovium; it only resembles synovial tis-
sue on light microscopy. It appears to arise from multipotent stem
Group Ltd. This is an open access article under the CC BY-NC-ND license (http://
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aig. 1. (A) Chest X-ray showed a large mass in left thoracic cavity. (B) CT scan of the
hest revealed a 14 cm heterogeneously anterior mediastinal mass.
ells that are capable of differentiating into mesenchymal and/or
pithelial structures and lack synovial differentiation [3,4].
Less than 10–20% of Synovial sarcoma arise in extra-
xtremity locations [5,6]. Generally, Soft tissue sarcomas, including
ngiosarcoma, leiomyosarcoma, sarcomatoidmesothelioma, rhab-
omyosarcoma, and Synovial sarcoma, account for less than 0.01%
f all malignant thoracic neoplasms [7]. According to data from a
arge population based study, around 17% of new cases of soft tissue
arcomas (including variety of histologic subtypes) arise in thoracic
ocations including the pleura, lungs, and the mediastinum with an
pproximate incidence of 6 per million populations [8]. Neverthe-
ess, there are no data that accurately report the exact incidence
f Synovial sarcoma cases that arise primarily in the mediastinum.
orphologically, synovial sarcomas are divided into monophasic
nd biphasic subtypes. The biphasic variant consists of prolifera-
ion of bland looking spindle-shaped cells, along with evidence of
pithelial differentiation. Monophasic subtypes on the other hand
an show either spindle cells only or occasionally epithelial compo-
ent only [9]. A poorly differentiated variant of synovial sarcoma is
lso recognised [10]. The differential diagnosis of a primary synovialFig. 2. (A) tumor removed at sternotomy. (B) Histology demonstraiting spindle and
epithelioid cells.
sarcoma in the mediastinum is complex as a wide array of primary
and metastatic tumours occur in this site. Immunohistochemistry
can be very helpful. Immunostains are valuable and supportive for
the diagnosis of a suspected case of synovial sarcoma. The expres-
sion of epithelial markers in the gland-like component and more
importantly in the spindle cell component supports the diagnosis.
EMA  is the most commonly positive marker among all epithelial
markers [10]. Pan-cytokeratin and cytokeratins 7 and 19 can also
be positive in the epithelial-like component as well as the spindle
cell component [11]. In addition, positivity for bcl-2 can be seen in
some cases [12].
Accurate staging of the disease is important for appropriate
patient management and requires the evaluation of the primary
tumor and assessment for distant disease. Magnetic resonance
imaging (MRI) has been the traditional imaging tool for assessment
of soft tissue masses, but more recently soft tissue sarcomas are
well recognised as showing increased 18F-FDG uptake in Positron
Emission Tomography [PET] [13]. Broad surgical resection is the
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ornerstone of therapy. Complete resection of the tumor was  the
verwhelming factor in determining survival in a review of primary
ediastinal sarcomas [14]. Radiotherapy is recommended with
ositive margins [15]. The place for chemotherapy of this tumor
s not well deﬁned, and in none of the other case reports was pre-
perative chemotherapy given [16]. Combination of adriamycine
nd ifosfamide has been used as an adjuvant therapy and for recur-
ences [16]. Traditionally, synovial sarcoma has been considered
o have a poor prognosis with metastasis occurring in 50% of the
ases. The lung is the most common site for metastasis followed by
ymph nodes and bone. However, not all synovial sarcomas share
he same dismal outcome anymore. Spillane et al. demonstrated
hat an age >20 year at diagnosis and size >5 cm were associated
ith a signiﬁcantly worse prognosis [17,18]. However, prognosis
fter aggressive multimodal therapy is good and survival up to 14
ears has been documented [19].
. Conclusion
The mediastinum is an uncommon site of occurrence of syn-
vial sarcoma that occurred in index case. Synovial sarcoma must
e entertained in the differential diagnosis of spindle cell as well
s biphasic tumours arising in the mediastinum. This case report
mphasizes the importance of prompt clinical suspicion, accurate
istopathological diagnosis, and use of appropriate immunohis-
ochemical markers in the diagnosis of this unusual tumor in an
nusual site.Aggressive multimodal therapy is recommended and
ur patient has responded to surgery and chemotherapy.
onﬂicts of interest
No conﬂicts of interest.
unding
No.
thical approval
None.
onsent
Consent has been obtained.
uthor contributionReza Ershadi: corresponding author-ﬁrst author.
Mohamad Bagher Rahim: assistant in surgery.
Hamidreza Davari: assistant in surgery.
[
pen Access
his article is published Open Access at sciencedirect.com. It is distrib
ermits unrestricted non commercial use, distribution, and reproduct
redited.PEN  ACCESS
gery Case Reports 27 (2016) 169–171 171
Guarantor
Reza Ershadi.
References
[1] M.D. Murphey, M.S. Gibson, B.T. Jennings, A.M. Crespo-Rodrıguez, J.
Fanburg-Smith, D.A. Gajewski, From the archives of the AFIP: imaging of
synovial sarcoma with radiologic–pathologic correla-tion, Radiographics 26
(2006) 1543–1565.
[2] Pathology and genetics of tumours of soft tissue and bone, in: C.D.M. Fletcher,
K.K. Unni, F. Mertens (Eds.), World Health Organization Classiﬁcation of
Tumours, IARC Press, Lyon, 2002.
[3] H.J. -Siegel, W.  Sessions, M.A. Casillas Jr., N. Said-Al-Naief, P.H. Lander, R.
Lopez-Ben, et al., Synovial-sarcoma clinicopathologic features treatment and
prognosis, Orthopedics 30 (2007) 1020–1025.
[4] M.  Peoc’h, F. Le Marc’hardour, F. Bost, D. Pasquier, J.J. Roux, N. Pinel, et al.,
Primary synovial sarcoma of the mediastinum. A case report with immune
histochemistry, ultrastructural and cytogenetic study, Ann. Pathol. 15 (1995)
203–206.
[5] M.D. Murphey, M.S. Gibson, B.T. Jennings, A.M. CrespoRodrı´ıguez, J.
Fanburg-Smith, D.A. Gajewski, From the archives of the AFIP: imaging of
synovial sarcoma with radiologic-pathologic correlation, Radiographics 26 (5)
(2006) 1543–1565.
[6] P.J. O’sullivan, A.C. Harris, P.L. Munk, Radiological features of synovial cell
sarcoma, Br. J. Radiol. 81 (964) (2008) 346–356.
[7] D.M. Salter, Pulmonary and thoracic sarcomas, Curr. Diagn. Pathol. 12 (6)
(2006) 409–417.
[8] F. Ducimeti‘ere, A. Lurkin, D. Ranch‘ere-Vince, et al., Incidence of sarcoma
histotypes and molecular subtypes in a prospective epidemiological study
with central pathology review and molecular testing, PLoS One 6 (8) (2011),
e20294.
[9] C. Eilber, S.M. Dry, Diagnosis and management of synovial sarcoma, J. Surg.
Oncol. 97 (4) (2008) 314–320.
10] S. Rossi, A.G. Nascimento, F. Canal, A.P. Dei Tos, Small round-cell neoplasms of
soft tissues: an integrated diagnostic approach, Curr. Diagn. Pathol. 13 (2)
(2007) 150–163.
11] M.  Miettinen, J. Limon, A. Niezabitowski, J. Lasota, Patterns of keratin
polypeptides in 110 biphasic, monophasic, and poorly differentiated synovial
sarcomas, Virchows Arch. 437 (3) (2000) 275–283.
12] N. Hirakawa, T. Naka, I. Yamamoto, T. Fukuda, M. Tsuneyoshi, Overexpression
of  bcl-2 protein in synovial sarcoma: a comparative study of other soft tissue
spindle cell sarcomas and an additional analysis by ﬂuorescence in situ
hybridization, Hum. Pathol. 27 (10) (1996) 1060–1065.
13] H. Jadvar, S. Gamie, L. Ramanna, P.S. Conti, Musculoskeletal system, Semin.
Nucl. Med. 34 (4) (2004) 254–261.
14] M.  Burt, J.K. Ihde, S.I. Hajdu, J.W. Smith, M.S. Bains, R. Downey, et al., Primary
sarcomas of the mediastinum: results of therapy, J. Thorac. Cardiovasc. Surg.
115 (3) (1998) 671–680, Correct reference.
15] N. Al-Rajhi, S. Husain, R. Coupland, C. McNamee, N. Jha, Primary pericardial
synovial sarcoma: a case report and literature review, J. Surg. Oncol. 70 (3)
(1999) 194–198.
16] G. Van der Mieren, S. Williems, R. Sciot, H. Dumez, A. Van Oosterom, W.
Flameng, et al., Pericardial synovial sarcoma: 14-year survival with
multimodality therapy, Ann. Thorac. Surg. 78 (3) (2004) e41–e42.
17] S.W. Weiss, J. Goldblum, Malignant soft tissue tumors of uncertain type, in:
S.W. Weiss, J.R. Goldblum (Eds.), Enzinger and Weiss’s Soft Tissue Tumors, CV
Mosby, St Louis, Missouri, 2001, pp. 1483–1571.
18] A.J. Spillane, R. A’Hern, I.R. Judson, C. Fisher, J.M. Thomas, Synovial
sarcoma:clinicopathologic, staging and prognostic assessment, J. Clin. Oncol.
18 (2000) 3794–3803.
19] G. Van der Mieren, S. Willems, H. Dumez, A. Van Oosterom, Pericardial
synovial sarcoma: 14-year survival with multimodality therapy, Ann. Thorac.
Surg. 78 (2004) e41–e42.uted under the IJSCR Supplemental terms and conditions, which
ion in any medium, provided the original authors and source are
